Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 31 March 2009, doi:10.1136/bmj.b1304
Cite this as: BMJ 2009;338:b1304
| The first 150 words of the full text of this article appear below. |
Echocardiography1 has resulted in the belief that heart failure and reduced ejection fraction are synonymous. Recently, however, the utility of ejection fraction in diagnosis has been undermined by epidemiological studies, which have shown that ejection fraction is continuously distributed in populations with heart failure,2 and that survival is the same irrespective of whether there is heart failure with normal ejection fraction (HFNEF) or with reduced ejection fraction (HFREF).3 4 In effect it is the clinical label of heart failure that drives prognosis, not the ejection fraction. The adoption of a dichotomous value (the division of cardiac function into normal and reduced ejection fraction) to describe a continuous variable is now outmoded and unhelpful.
The relative lack of benefit in studies in HFNEF may be a failure of the therapeutic modes of action of the drugs studied, since there is no physiological reason why afterload reduction in non-dilated hearts will produce prognostic
Hugh F McIntyre, consultant physician
1 East Sussex NHS Trust, Conquest Hospital, Hastings TN37 7RD
Hugh.mcintyre@esht.nhs.uk